Cost-effectiveness of implantable cardioverter-defibrillators in Brugada syndrome treatment

Journal of Medical Systems

Volumn 32, Issue 1, 2008, Pages 51-57

  Wang, Kai ^a   Yamauchi, Kazunobu ^a   Li, Ping ^a   Kato, Hiroki ^a   Kobayashi, Makoto ^b   Kato, Ken ^a   Shimizu, Yoshiyuki ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Healtheconomics Research Group   (Japan)

^c Department of Surgery   (Japan)

Author keywords

Brugada syndrome; Control therapy; Cost effectiveness; Implantable cardioverter defibrillators

Indexed keywords

PROPRANOLOL; QUINIDINE;

ANALYTIC METHOD; ARTICLE; BRUGADA SYNDROME; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; HUMAN; PROPHYLAXIS; QUALITY OF LIFE; RISK; SUDDEN DEATH; SURVIVAL;

BRUGADA SYNDROME; COHORT STUDIES; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; HUMANS; JAPAN; QUALITY-ADJUSTED LIFE YEARS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 37849020691     PISSN: 01485598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10916-007-9107-7     Document Type: Article

References (34)

1. Nademanee, K., Veerakul, G., Nimmannit, S., et al., Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 96:2595-2600, 1997.
2. Miyasaka, Y., Tsuji, H., Yamada, K., Tokunaga, S., Saito, D., Imuro, Y., Matsumoto, N., and Iwasaka, T., Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J. Am. Coll. Cardiol. 38:771-774, 2001.
3. Hermida, J. S., Lemoine, J. L., Aoun, F. B., Jarry, G., Rey, J. L., and Quiret, J. C., Prevalence of the Brugada syndrome in an apparently healthy population. Am. J. Cardiol. 86:91-94, 2000.
4. Brugada, P., and Brugada J., Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J. Am. Coll. Cardiol. 20:1391-1396, 1992.
5. Connolly, S. J., Gent, M., Roberts, R. S., et al., CIDS Investigators. Canadian Implanted Defibrillator Study (CIDS). A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297-1302, 2000.
6. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Eng. J. Med. 337:1576-1583, 1997.
7. Moss, A. J., Hall, W. J., Cannom, D. S., et al., Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease and high risk for ventricular arrhythmia. N. Engl. J. Med. 335:1933-1944, 1996.
8. Siebels, J., Kuck, K. H., and CASH Investigators, Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am. Heart J. 127:1139-1144, 1994.
9. Bigger, J. T., Whang, W., Rottman, J. N., et al., Mechanisms of death in the CABG Patch trial: a randomized trial of implanted cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass grafting surgery. Circulation 99:1416-1421, 1999.
10. Kadish, A., Dyer, A., Daubert, J. P., et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Eng. J. Med. 350:2151-2158, 2004.
11. Lee, K. L., Hafley, G., Fisher, J. D., et al., Multicenter Unsustained Tachycardia Trial Investigators. Effect of implantable defibrillators on the arrhythmic events and mortality in the Multicenter Unsustained Tachycardia Trial. Circulation 106:233-238, 2002.
12. National Center for Health Statistics, Health, United States, 2002: with chartbook on trends in the health of Americans. National Center for Health Statistics (DHHS publication no.): Hyattsville, MD, 2002.
13. Schron, E. B., et al., Quality of life in the Antiarrhythmics Versus Implantable Defibrillators Trial. Circulation 105:589-594, 2002.
14. Brugada, J., Brugada, R., and Brugada, P., Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 97:457-460, 1998.
15. Belhassen, B., Viskin, S., and Antzelevitch, C., The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin. Electrophysiol. 25:1634-1640, 2002.
16. Alings, M., Dekker, L., Sadee, A., and Wilde, A., Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin. Electrophysiol. 24:1420-1422, 2001.
17. Antzelevitch, C., Brugada, P., Brugada, J., Brugada, R., Nademanee, K., and Towbin, J. A., Clinical approaches to tachyarrhythmias. The Brugada syndrome. Futura: Armonk, NY, 1999.
18. Koonlawee Nademanee, M. D., et al., Defibrillator versus β-blockers for unexplained death in Thailand (DEBT). Circulation 107:2221-2226, 2003.
19. Bernard belhassen, M. D., Aharon Glick, M. D., and Sami Viskin, M. D., Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110:1731-1737, 2004.
20. Hermida, J. S., Denjoy, I., Clerc, J., et al., Hydroquinidine therapy in Brugada syndrome. J. Am. Coll. Cardiol. 43:1853-1860, 2004.
21. Hauser, R. G., The growing mismatch between patient longevity the service life of implantable cardioverter-defibrillators. J. Am. Coll. Cardiol. 45(12):2022-2025, 2005.
22. Gabry, M. D., Brodman, R., Johnston, D., et al., Automatic implantable cardioverter-defibrillator: patient survival, battery longevity and shock delivery analysis. JACC 9(6):1349-1356, 1987.
23. Fryback, D. G., Dasbach, E. J., Klein, R., et al., The Beaver Dam health outcomes study: initial catalog of health state quality factors. Med. Decis. Mak. 13:89-102, 1993.
24. Lipscomb, J., Weinstein, M. C., and Torrance, G. W., In: Gold, M. R., Siegel, J. E., Russell, L. B., and Weinstein, M. C., (Eds.), Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 214-246, 1996.
25. Belhassen, B., Viskin, S., Fish, R., et al., Effects of electrophysiologic-guided therapy with class 1A antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J. Cardiovasc. Electrophysiol. 10:1301-1312, 1999.
26. Belhassen, B., Shapira, I., Shoshani, D., et al. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 75:809-816, 1987.
27. Hohnloser, S. H., Kuck, K. H., Dorian, P., et al., Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 351:2481-2488, 2004.
28. Bristow, M. R., Saxon, L. A., Boehmer, J., et al., Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350:2140-2150, 2004.
29. Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., and Hafley, G., A randomized study of the prevention of sudden death in patients with coronary artery disease. N. Engl. J. Med. 341:1882-1890, 1999. [Erratum, N Engl J Med 2000; 342:1300].
30. Litovsky, S. H., and Antzelevitch, C., Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ. Res. 67:615-627, 1990.
31. Suzuki, H., Torigoe, K., Numata, O., and Yazaki, S., Infant case with a malignant form of Brugada syndrome. J. Cardiovasc. Electrophysiol. 11:1277-1280, 2000.
32. Tanaka, H., Kinoshita, O., Uchikawa, S., Kasai, H., Nakamura, M., Izawa, A., Yokoseki, O., Kitabayashi, H., Takahashi, W., Yazaki, Y., Watanabe, N., Imamura, H., and Kubo, K., Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin. Electrophysiol. 24:1293-1294, 2001.
33. Nademanee, K., Veerakul, G., Nimmannit, S., Chaowakul, V., Bhuripanyo, K., Likittanasombat, K., Tunsanga, K., Kuasirikul, S., Malasit, P., Tansupasawadikul, S., and Tatsanavivat, P., Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 96:2595-2600, 1997.
34. Antzelevitch, C., Brugada, P., et al., Brugada Syndrome Report of the second consensus conference. Circulation 111:659-670, 2005.